যুক্তরাজ্য - ইংরেজি - MHRA (Medicines & Healthcare Products Regulatory Agency)

alliance healthcare (distribution) ltd - sodium bicarbonate; magnesium carbonate light - oral suspension - 50mg/1ml ; 30mg/1ml

মার্কিন যুক্তরাষ্ট্র - ইংরেজি - NLM (National Library of Medicine)

aurolife pharma, llc - omeprazole (unii: kg60484qx9) (omeprazole - unii:kg60484qx9), sodium bicarbonate (unii: 8mdf5v39qo) (bicarbonate ion - unii:hn1zra3q20) - acid reducer allows absorption of this omeprazole product - treats frequent heartburn (occurs 2 or more days a week) - not intended for immediate relief of hearburn. this drug may take 1 to 4 days for full effect. - touble or pain swallowing food - vomiting with blood - bloody or black stools these may be signs of a serious condition. see your doctor. - had heartburn over 3 months.  this may be a sign of a more serious condition. - heartburn with lightheadedness, sweating or diziness - chest pain or shoulder pain with shortness of breath; sweating; pain spreading to arms, neck or shoulder; or lightheadedness - frequent chest pain - frequent wheezing, particularly with heartburn - unexplained weight loss - nausea or vomiting - stomach pain - a sodium-restricted diet - warfarin, clopidogrel or cilostazol (blood-thinning medicines) - prescription antifungal or anti-yeast medicines - diazepam (anxiety medicine) - digoxin (heart medicine) - tacrolimus or mycophenolate mofetil (immune system medicine) - prescri

মার্কিন যুক্তরাষ্ট্র - ইংরেজি - NLM (National Library of Medicine)

baxter healthcare corporation - magnesium sulfate heptahydrate (unii: sk47b8698t) (magnesium cation - unii:t6v3lhy838) - magnesium sulfate in 5% dextrose injection is indicated for: magnesium sulfate in 5% dextrose injection is contraindicated in patients: risk summary magnesium sulfate in 5% dextrose injection is indicated in pregnant women for the prevention of eclampsia in women with preeclampsia and the treatment of seizures and prevention of recurrent seizures in women with eclampsia. fetal, neonatal, and maternal risks are discussed throughout the labeling. clinical considerations labor or delivery: magnesium sulfate in 5% dextrose injection is not approved for the treatment of pre-term labor. administration of magnesium sulfate in 5% dextrose injection to pregnant women longer than 5 to 7 days may lead to hypocalcemia and bone abnormalities in the developing fetus, including skeletal demineralization and osteopenia [see warnings and precautions (5.1)] . the use of intravenous magnesium in pregnant women increases human milk magnesium concentrations only slightly and oral absorption of magnesium by the infant

মার্কিন যুক্তরাষ্ট্র - ইংরেজি - NLM (National Library of Medicine)

mylan institutional llc - magnesium sulfate heptahydrate (unii: sk47b8698t) (magnesium cation - unii:t6v3lhy838) - magnesium sulfate in 5% dextrose injection is indicated for: magnesium sulfate in 5% dextrose injection is contraindicated in patients: risk summary magnesium sulfate in 5% dextrose injection is indicated in pregnant women for the prevention of eclampsia in women with preeclampsia and the treatment of seizures and prevention of recurrent seizures in women with eclampsia. fetal, neonatal, and maternal risks are discussed throughout the labeling. clinical considerations labor or delivery: magnesium sulfate in 5% dextrose injection is not approved for the treatment of pre-term labor. administration of magnesium sulfate in 5% dextrose injection to pregnant women longer than 5 to 7 days may lead to hypocalcemia and bone abnormalities in the developing fetus, including skeletal demineralization and osteopenia [see warnings and precautions (5.1)] . the use of intravenous magnesium in pregnant women increases human milk magnesium concentrations only slightly and oral absorption of magnesium by the infant is poor. th

মার্কিন যুক্তরাষ্ট্র - ইংরেজি - NLM (National Library of Medicine)

b. braun medical inc. - magnesium sulfate heptahydrate (unii: sk47b8698t) (magnesium cation - unii:t6v3lhy838) - magnesium sulfate in 5% dextrose injection is indicated for: - prevention of eclampsia in patients with preeclampsia - treatment of seizures and prevention of recurrent seizures in patients with eclampsia magnesium sulfate in 5% dextrose injection is contraindicated in patients: - with heart block or myocardial damage - in diabetic coma - with myasthenia gravis [see warnings and precautions (5.6)] risk summary magnesium sulfate in 5% dextrose injection is indicated in pregnant women for the prevention of eclampsia in women with preeclampsia and the treatment of seizures and prevention of recurrent seizures in women with eclampsia. fetal, neonatal, and maternal risks are discussed throughout the labeling. clinical considerations labor or delivery: magnesium sulfate in 5% dextrose injection is not approved for the treatment of pre-term labor. administration of magnesium sulfate in 5% dextrose injection to pregnant women longer than 5 to 7 days may lead to hypocalcemia and bone abnormalities in the developing fe

অস্ট্রেলিয়া - ইংরেজি - Department of Health (Therapeutic Goods Administration)

accord healthcare pty ltd - levothyroxine sodium, quantity: 200 microgram - tablet, uncoated - excipient ingredients: light magnesium oxide; sodium starch glycollate; sodium stearylfumarate; microcrystalline cellulose; allura red ac aluminium lake - levothox is indicated for the management of demonstrated thyroid hormone deficiency.,levothox is also used to suppress thyrotropin (tsh) for the management of tsh-responsive tumours of the thyroid.

অস্ট্রেলিয়া - ইংরেজি - Department of Health (Therapeutic Goods Administration)

accord healthcare pty ltd - levothyroxine sodium, quantity: 75 microgram - tablet, uncoated - excipient ingredients: light magnesium oxide; sodium stearylfumarate; sodium starch glycollate; microcrystalline cellulose; allura red ac aluminium lake; indigo carmine aluminium lake - levothox is indicated for the management of demonstrated thyroid hormone deficiency.,levothox is also used to suppress thyrotropin (tsh) for the management of tsh-responsive tumours of the thyroid.

নামিবিয়া - ইংরেজি - Namibia Medicines Regulatory Council

gulf drug company (pty) ltd - magnesium carbonate, light, magnesium trisilicate, sodium bicarbonate - mixture - each 10 ml mixture contains: magnesium carbonate, light 500,0mg, magnesium trisilicate 500,0mg, sodium bicarbonate 500,0mg

নামিবিয়া - ইংরেজি - Namibia Medicines Regulatory Council

universal pharmaceuticals (pty) ltd - light magnesium carbonate, magnesium trisilicate, sodium bicarbonate - mixture - each 15ml of suspension contains: 60mg light magnesium carbonate, 650mg magnesium trisilicate, 650mg sodium bicarbonate

ইস্রায়েল - ইংরেজি - Ministry of Health

isorad ltd, israel - iodine sodium - capsules - iodine sodium 37 mbq - sodium iodide (131i) - sodium iodide (131i) - treatment of graves disease, toxic multinodular goite or autonomous nodules.treatment of papillary and follicular thyroid carcinoma including metastatic disease. sodium iodide (i-131) therapy is often combined with surgical intervention and with antithyroid medications.